Participants in The Leukemia and Lymphoma Society (LLS) National Research Registry will be invited to participate in the LLS Covid-19 Registry to evaluate medical outcomes for people with blood cancer, who have been diagnosed with COVID-19, have received, or are planning to receive, a COVID-19 vaccination.
If you are or have been a blood cancer patient, please consider joining the Registry today, especially if you have been diagnosed with COVID-19 or if you have been vaccinated against COVID-19 or plan to be. Joining is safe, easy, and free. If you need assistance with joining the Registry, please call 1-855-244-8493 or visit the Michael Garil National Patient Registry page.
| SparkCures ID | 1155 |
|---|---|
| Enrollment | 1000 Patients |
| Tags |
|
| Trial Sponsors |
|
| NCT Identifier |
|
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
Inclusion Criteria:
Exclusion Criteria:
Please visit the ClinicalTrials.gov page for historical site information.
View Centers